Like AlphaDetail, Inc.

closed 3/23/2012 via BusinessWire

ImpactRx, Inc., acquired AlphaDetail, Inc.

See 71 Comparable Transactions
synopsis: ImpactRx, a Symphony Technology Group company, and the pioneer in measuring the impact of promotion on physicians’ attitudes and prescribing behavior, announced that it has acquired AlphaDetail, Inc., a leader in global healthcare primary market research and influence network mapping.
buyer parent: Symphony Technology Group
buyer: ImpactRx, Inc.
ImpactRx is the leading provider of consultative and analytically-based promotional effectiveness solutions to the healthcare industry. ImpactRx's ImpactData™ is the industry’s sole source of continuous-capture market promotion and physician treatment data. "
 target: AlphaDetail, Inc.
AlphaDetail is a rapidly growing global market research consulting company focused on the pharmaceutical and biotechnology industry. It uses the Internet as a channel to enable rapid, convenient, and effective communication between pharmaceutical companies, healthcare professionals and patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/14/2020 via PR Newswire

Medical Knowledge Group LLC, acquired Magnolia Innovation, LLC

See 84 Comparable Transactions
synopsis: Medical Knowledge Group, LLC, an analytics-driven and technology-enabled multichannel health care marketing and communications conglomerate whose operating companies serve the biopharmaceutical industry, has acquired Magnolia Innovation, a premier market research and strategy consulting firm.
buyer parent: Court Square Capital Partners
buyer: Medical Knowledge Group LLC
Medical Knowledge Group, through its operating companies, provides specialized medical communications services, proprietary analytic solutions, and market research services to the biopharmaceutical industry. "
 target: Magnolia Innovation, LLC
Magnolia Innovation is a market research and consulting firm focusing exclusively in the life sciences. Magnolia has decades of combined experience building, launching, and redefining biopharmaceutical brands to drive innovation through insights.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/1/2018 via Company Press Release

BioInformatics Inc., acquired Kalorama Information

See 82 Comparable Transactions
synopsis: BioInformatics Inc., the premier research and advisory company serving the life science industry, has acquired Kalorama Information from MarketResearch. Kalorama Information is a leading publisher of market research in healthcare areas, including in vitro diagnostics, imaging, biotechnology, healthcare, medical devices, and pharmaceuticals.
buyer: BioInformatics Inc.
BioInformatics Inc. is the leading research and advisory firm serving the life science, diagnostic and analytical instrument industries. Their expertise includes assessing the size and attractiveness of markets, optimizing product configurations and pricing and validating corporate acquisitions. "
 target parent: MarketResearch.com, Inc.
target: Kalorama Information
Kalorama Information is a leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), imaging, biotechnology, healthcare, medical devices, and pharmaceuticals. Kalorama only publishes in healthcare.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/6/2017 via Company Press Release

The Access Group, acquired Health Strategies Group

See 71 Comparable Transactions
synopsis: Water Street Healthcare Partners, through its subsidiary, The Access Group, has acquired Health Strategies Group. Health Strategies Group is the leader in market access intelligence and customized research for pharmaceutical and biotech professionals. It dissects trends and identifies opportunities to help companies optimize their product access.
buyer parent: Water Street Healthcare Partners
buyer: The Access Group
The Access Group offers a breadth of services to clients, from traditional “block-and-tackle” launch execution tactics to in-depth market assessments. The company is dedicated to complete product life cycle management, creating brand solutions that drive demand across multiple stakeholder channels. "
 target: Health Strategies Group
Health Strategies Group offers a dedicated team of research leaders committed to dissecting the trends, identifying customer needs, and pinpointing the barriers and opportunities for biopharma within the evolving health care environment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/15/2015 via PR Newswire

Insignia Capital Group, acquired Metanexgen, Inc.

See 619 Comparable Transactions
synopsis: Insignia Capital Group announced the acquisition of metanexgen from DFW Capital Partners. Based in Bensalem, PA, metanexgen is a provider of technology-enabled multi-channel marketing solutions that allow pharmaceutical, biotechnology and medical device brands to effectively market their products to healthcare practitioners.
buyer: Insignia Capital Group
Insignia Capital is a private equity firm working with lower-middle market companies. Insignia Capital works with a wide variety of companies but their specialty is consumer, business services and healthcare. "
 target parent: DFW Capital Partners
target: Metanexgen, Inc.
Metanexgen is a provider of technology-enabled multi-channel marketing solutions that allow pharmaceutical, biotechnology and medical device brands to effectively market their products to healthcare practitioners.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/12/2014 via Company Press Release

Everyday Health, Inc., will acquire DoctorDirectory.com

See 99 Comparable Transactions
synopsis: Everyday Health signed a definitive agreement to acquire DoctorDirectory. Based in North Carolina, DoctorDirectory provides pharmaceutical companies with multi-channel marketing services that target healthcare professionals. DoctorDirectory.com, Inc. also operates as an online directory for finding a doctor by specialty.
buyer: Everyday Health, Inc. (EVDY:$253.92)
Everyday Health, Inc. is a provider of digital health and wellness solutions. They attract consumers and healthcare professionals to their health and wellness properties, and utilize their data and analytics to deliver personalized content experiences and marketing and engagement solutions. "
 target: DoctorDirectory.com
DoctorDirectory.com, Inc. operates as an online directory for finding a doctor by specialty. They also provide Healthcare Professionals the opportunity to participate in Market Research and other programs that help shape the healthcare industry.
price ($mm)
$65
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/16/2014 via Company Press Release

BioPharm Communications, LLC, acquired Carson Analytics

See 3 Comparable Transactions
synopsis: BioPharm Communications, a portfolio company of Southfield Capital and minority shareholder Boathouse Capital has announced the acquisition of Carson Analytics. Carson Analytics is a leading provider of integrated commercial analytics solutions for the pharmaceutical and biotechnology industries.
buyer parent: Southfield Capital Advisors
buyer: BioPharm Communications, LLC
BioPharm develops promotional medical education programs for customers in the pharmaceutical and biotechnology industries. The company creates robust clinical content in collaboration with key opinion leaders and delivers it to healthcare practitioners through the company's comprehensive suite. "
 target: Carson Analytics
Carson Analytics is a leading provider of integrated commercial analytics solutions for the pharmaceutical and biotechnology industries. They provide advanced analytics solutions including forecasting, promotion response analysis and optimization of promotion mix.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/28/2013 via BusinessWire

QPharma, Inc., acquired MD Mindset, LLC

See 71 Comparable Transactions
synopsis: QPharma has announced its acquisition of MD Mindset, LLC, a leading physician research firm focused on improving pharmaceutical sales force and marketing effectiveness. The Atlanta, GA-based company will transition operations of MD Snapshot, MD Feedback, MD Fellowship, and iSFE Tracker products and services to Morristown, New Jersey.
buyer: QPharma, Inc.
QPharma provides regulatory compliance and brand support for the pharmaceutical, medical device and other life sciences industries. Sample services include remediation consulting, validation services, project management & auditing, aggregate spend reporting, sample accountability & online training. "
 target: MD Mindset, LLC
MD Mindset, founded in 2001, was established to help pharmaceutical and life sciences sales professionals maximize their performance and effectiveness when calling on healthcare professionals for sales details.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/28/2016 via BNC Analysis

AplusA, acquired Bell Falla & Associates LLC

See 76 Comparable Transactions
synopsis: AplusA buys Bell Falla to become a leading international marketing research for the pharmaceutical industry and the health sector. Bell Falla is an international market research and consulting firm for pharmaceutical, biotech and medical device companies. With the acquisition, AplusA plans to establish itself as a major player in the global market.
buyer: AplusA
AplusA is a reputable medical market research firm that specializes in international, primary research for the Pharmaceutical, Biotechnology and Medical Device Industries. For over 25 years, AplusA has been guiding lifecycle management of the most innovative healthcare products worldwide. "
 target: Bell Falla & Associates LLC
Bell Falla & Associates is an international market research and consulting firm for pharmaceutical, biotech and medical device companies. They provide both qualitative and quantitative research using state of the art research methodologies, as well as statistical consulting and marketing consulting.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/26/2005 via PR Newswire

Greenfield Online, Inc., acquired Rapidata.net, Inc.

See 83 Comparable Transactions
synopsis: Greenfield Online, Inc SRVY, a leading provider of Internet survey solutions to marketing research and consulting companies, today announced it has completed the acquisition of Rapidata.net, Inc., a privately-held North Carolina corporation, for $5.5 million in cash, subject to certain post closing adjustments.
buyer: Greenfield Online, Inc. (SRVY:$0.00)
Greenfield Online, Inc. is a global interactive media and services company that collects consumer attitudes about products and services, enabling consumers to reach informed purchasing decisions about the products and services they want to buy; and helping companies better understand their customer."
 target: Rapidata.net, Inc.
Founded fifteen years ago by research pharmacist and professor David P. Lipson, R.PH., Ph.D., Rapidata.net connects pharmaceutical market researchers to healthcare providers and their patients. This connection allows pharmaceutical market researchers to learn more about the prescription medications
price ($mm)
$5.50
rev ($mm)
$2
EBITDA ($mm)
EV / rev
2.6x
EV / EBITDA
closed 7/24/2013 via Reuters

Cross Marketing, acquired MedePanel

See 83 Comparable Transactions
synopsis: Cross Marketing Group has announced the acquisition of MedePanel, a result-oriented research firm, headquartered in New Jersey. MedePanel supports healthcare business decisions by providing insights from patients, healthcare practitioners and other key healthcare stakeholders.
buyer: Cross Marketing (TSE:3675:$80.11)
Cross Marketing provides a full range of one-stop marketing research services based on their online research DNA, and continuing to evolve further into a marketing solution partner for their clients. "
 target: MedePanel
MedePanel Online Inc is a result-oriented research firm, headquartered in New Jersey providing local account management support. MedePanel supports healthcare business decisions by providing insights from patients, healthcare practitioners and other key healthcare stakeholders.
price ($mm)
$3.96*
rev ($mm)
$4
EBITDA ($mm)
EV / rev
2.2x
EV / EBITDA
closed 7/19/2012 via PR Newswire

WorldOne, acquired Sermo

See 15 Comparable Transactions
synopsis: WorldOne, the global leader in healthcare insights and intelligence, announced that it has acquired Sermo, the largest online community of U.S. physicians. Sermo has amassed a membership of 130,000 physicians and hundreds of clients, including eight of the top ten pharmaceutical companies in the world.
buyer: WorldOne
WorldOne is the largest healthcare data collection company in the world serving the market research industry. WorldOne offers clients online and offline access to medical professionals in over 80 countries through a range of differentiated products and services. "
 target: Sermo
Sermo is the largest online physician community in the United States. All Sermo members are verified and credentialed physicians who collaborate on cases and exchange observations to improve patient care, discuss drugs and devices and share information on new therapies and innovations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/23/2011 via BusinessWire

M3 USA Corporation, acquired Doctors.net.uk

See 15 Comparable Transactions
synopsis: M3 USA announced the acquisition of Doctors.net.uk, the largest physician network in the United Kingdom. Doctors.net.uk is the most popular professional web portal and email service for physicians in the UK while providing digital promotion and market research services to the life science industry.
buyer parent: Sony Corporation
buyer: M3 USA Corporation
M3 USA, named to represent Medicine, Media, and Metamorphosis, was founded with the goal of changing the world of medicine through full use of the power of the Internet. M3 provides the life science industry with highly targeted interactive marketing, education, content, and research solutions. "
 target: Doctors.net.uk
Doctors.net.uk is a secure service offering a professional e-mail facility, clinical and non-clinical forums, the very latest medical news and free accredited education allowing doctors to maintain Continuing Professional Development (CPD).
price ($mm)
$21
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/7/2022 via BusinessWire

Information Resources, Inc. merged with NPD Group, Inc.,

See 237 Comparable Transactions
synopsis: Information Resources, Inc. (IRI), a fast-growing global leader in innovative solutions and services for consumer, retail and media companies, and The NPD Group, a global provider of market information and advisory services in more than 20 industries, have completed their merger.
buyer parent: Hellman & Friedman LLC
buyer: NPD Group, Inc.
NPD offers data, industry expertise, and prescriptive analytics to help its clients grow their businesses in a changing world. Over 2000 companies worldwide rely on NPD to help them measure, predict, and improve performance across all channels, including brick-and-mortar and e-commerce. "
 target parent: Vestar Capital Partners
target: Information Resources, Inc.
Information Resources, Inc. is a leading provider of big data, predictive analytics and forward-looking insights that help CPG companies, OTC health care organizations, retailers, financial services and media companies grow their businesses.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/1/2021 via GlobeNewswire

Cerner Corporation, acquired Kantar Health

See 78 Comparable Transactions
synopsis: Cerner Corporation, a global health care technology company, has acquired Kantar Health, a division of Kantar Group. Kantar Health is a leading data, analytics and real-world evidence and commercial research consultancy serving the life science industry.
buyer: Cerner Corporation (CERN:$5,707.53)
Cerner’s health technologies connect people and information systems at thousands of contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities. "
 target parent: Bain Capital
target: Kantar Health
Kantar Health SA provides healthcare consulting and marketing research services. The company was formerly known as Taylor Nelson Sofres Healthcare SA. The company is based in Madrid, Spain. Kantar Health SA operates as a subsidiary of WPP plc.
price ($mm)
$375
rev ($mm)
$150
EBITDA ($mm)
EV / rev
2.5x
EV / EBITDA
announced 11/16/2018 via Company Press Release

Vestar Capital Partners, will acquire Information Resources, Inc.

See 237 Comparable Transactions
synopsis: Vestar Capital Partners, a private equity firm, will lead a new investment in Information Resources, Inc., a leading provider of big data, predictive analytics and forward-looking insights. Jeffrey Ansell, a Vestar Senior Advisor, will serve as Chairman of IRI. New Mountain and other existing investors are retaining a meaningful investment in IRI.
buyer: Vestar Capital Partners
Vestar Capital Partners (VCP) is a private equity firm specializing in management buyouts and growth capital investments. VCP collaborates with management teams and private owners to build long- term enterprise value, with a focus on Consumer, Healthcare, and Business Services & Industrial Products."
 target parent: New Mountain Capital, LLC
target: Information Resources, Inc.
Information Resources, Inc. is a leading provider of big data, predictive analytics and forward-looking insights that help CPG companies, OTC health care organizations, retailers, financial services and media companies grow their businesses.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/2/2018 via PR Newswire

ZS Associates, purchased BASES Pharmaceutical Forecasting from The Nielsen Company, Inc.

See 61 Comparable Transactions
synopsis: ZS announced it has acquired the assets of BASES Pharmaceutical Forecasting from Nielsen. The BASES Pharmaceutical Forecasting assets include launch product and direct-to-consumer forecasting tools and proprietary normative databases for pharmaceutical brands.
buyer: ZS Associates
ZS Associates is a global management consulting firm specializing in sales and marketing strategy, operations and execution. Founded in 1983, ZS has grown into a firm of 500 professionals delivering expertise across much of the sales and marketing spectrum. "
 seller: The Nielsen Company, Inc. (NLSN:$3,500.00)
The BASES Pharmaceutical Forecasting assets include launch product and direct-to-consumer forecasting tools and proprietary normative databases for pharmaceutical brands.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/28/2012 via BNC Analysis

United Drug plc, will acquire Synopia RX, LLC

See 59 Comparable Transactions
synopsis: Irish healthcare services provider United Drug plc, announced an agreement to acquire Synopia RX LLC. SynopiaRx consults with BioTech and Pharmaceutical companies as well as investment organizations to deliver market intelligence, strategies and account management.
buyer: United Drug plc (LSE:UDG:$1,298.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
 target: Synopia RX, LLC
SynopiaRx engages with companies in the BioTech and Pharmaceutical industry to optimize their commercialization of medicines in the managed care marketplace.
price ($mm)
$3.20
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/8/2012 via PR Newswire

Diversified Agency Services, will acquire Medical Collective Intelligence Co. Ltd.

See 23 Comparable Transactions
synopsis: Diversified Agency Services announced an agreement with ITOCHU Corporation and a number of venture capital funds to acquire a majority stake in Medical Collective Intelligence Co. Ltd., a highly respected Japanese online medical communications agency.
buyer parent: Omnicom Group Inc.
buyer: Diversified Agency Services
Diversified Agency Services (DAS), a division of Omnicom Group Inc., manages Omnicom's holdings in a variety of marketing disciplines. DAS includes more than 190 companies, which operate through a combination of networks and regional organizations. "
 target parent: Itochu Corporation
target: Medical Collective Intelligence Co. Ltd.
Medical Collective Intelligence Co. Ltd. ("MCI") is a highly respected and well-known Japanese online medical communications agency. Based in Tokyo, MCI operates a Marketing Research division and a Detailing Solutions division, both focused on the healthcare industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/24/2012 via BusinessWire

IMS Health Incorporated, acquired PharmARC Analytic Solutions Pvt. Ltd.

See 159 Comparable Transactions
synopsis: IMS Health has acquired PharmARC, an India-based company specializing in commercial analytics and services for the life sciences industry. The acquisition adds significant scale to a world-class services delivery platform, strengthens IMS’s business process outsourcing capabilities.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
 target: PharmARC Analytic Solutions Pvt. Ltd.
PharmARC is a leading provider of analytic solutions for the efficient commercialization of drugs and medical products. The firm’s analytics and services enable its life sciences customers to make informed decisions related to their sales and marketing strategies and implementation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
Pages:  
closed 3/23/2012 via BusinessWire

ImpactRx, Inc., acquired AlphaDetail, Inc.

See 71 Comparable Transactions
synopsis: ImpactRx, a Symphony Technology Group company, and the pioneer in measuring the impact of promotion on physicians’ attitudes and prescribing behavior, announced that it has acquired AlphaDetail, Inc., a leader in global healthcare primary market research and influence network mapping.
buyer parent: Symphony Technology Group
buyer: ImpactRx, Inc.
ImpactRx is the leading provider of consultative and analytically-based promotional effectiveness solutions to the healthcare industry. ImpactRx's ImpactData™ is the industry’s sole source of continuous-capture market promotion and physician treatment data. "
 target: AlphaDetail, Inc.
AlphaDetail is a rapidly growing global market research consulting company focused on the pharmaceutical and biotechnology industry. It uses the Internet as a channel to enable rapid, convenient, and effective communication between pharmaceutical companies, healthcare professionals and patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/3/2016 via PR Newswire

IMS Health Incorporated, acquired AlphaImpactRx, Inc

See 82 Comparable Transactions
synopsis: Symphony Technology Group announced the closing of the sale of AlphaImpactRx, a leading provider of primary research and analytics-based insight for biopharmaceutical and consumer health companies to IMS Health, a global information and technology services company serving the healthcare industry.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
 target parent: Symphony Technology Group
target: AlphaImpactRx, Inc
AlphaImpactRx is the leading provider of primary research-based insights, analytics and solutions to pharmaceutical, consumer health and medical device companies. They provide market research to help its global healthcare clients make informed and business decisions to market their products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/14/2012 via Market Wire

ImpactRx, Inc., acquired Source Healthcare Analytics, LLC

See 151 Comparable Transactions
synopsis: Symphony Technology Group announced that it has acquired Source Healthcare Analytics, LLC. STG will combine Source Healthcare Analytics with ImpactRx to form Symphony Health Solutions, which will be focused on delivering high-value data, analytics, and technology based solutions for clients across life science manufacturers, payers, and providers.
buyer parent: Symphony Technology Group
buyer: ImpactRx, Inc.
ImpactRx is the leading provider of consultative and analytically-based promotional effectiveness solutions to the healthcare industry. ImpactRx's ImpactData™ is the industry’s sole source of continuous-capture market promotion and physician treatment data. "
 target parent: Wolters Kluwer NV
target: Source Healthcare Analytics, LLC
Source Healthcare Analytics is a leading provider of information and analytics to the pharmaceutical, biotech and financial industries. The company's brands include Source®, ProMetis™ and inThought™.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/23/2012 via BusinessWire

ImpactRx, Inc., acquired AlphaDetail, Inc.

See 71 Comparable Transactions
synopsis: ImpactRx, a Symphony Technology Group company, and the pioneer in measuring the impact of promotion on physicians’ attitudes and prescribing behavior, announced that it has acquired AlphaDetail, Inc., a leader in global healthcare primary market research and influence network mapping.
buyer parent: Symphony Technology Group
buyer: ImpactRx, Inc.
ImpactRx is the leading provider of consultative and analytically-based promotional effectiveness solutions to the healthcare industry. ImpactRx's ImpactData™ is the industry’s sole source of continuous-capture market promotion and physician treatment data. "
 target: AlphaDetail, Inc.
AlphaDetail is a rapidly growing global market research consulting company focused on the pharmaceutical and biotechnology industry. It uses the Internet as a channel to enable rapid, convenient, and effective communication between pharmaceutical companies, healthcare professionals and patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/13/2011 via PR Newswire

ImpactRx, Inc., acquired TargetRx, Inc.

See 4 Comparable Transactions
synopsis: ImpactRx, a Symphony Technology Group company and the pioneer in measuring the impact of promotion on physician prescribing behavior, announced that it has acquired 100% of TargetRx, Inc., a leading provider of insight into the drivers of physician behavior for pharmaceutical companies.
buyer parent: Symphony Technology Group
buyer: ImpactRx, Inc.
ImpactRx is the leading provider of consultative and analytically-based promotional effectiveness solutions to the healthcare industry. ImpactRx's ImpactData™ is the industry’s sole source of continuous-capture market promotion and physician treatment data. "
 target: TargetRx, Inc.
TargetRx, Inc. is a leading provider of insight into the drivers of physician behavior for pharmaceutical companies. The company offers a suite of solutions from pipeline to patent expiry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/18/2011 via PR Newswire

Symphony Technology Group, acquired ImpactRx, Inc.

See 4 Comparable Transactions
synopsis: ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior, announced that Symphony Technology Group (STG), has acquired a majority ownership interest in the Company. STG is a leading private equity firm with a strategic focus on data, analytics and technology-enabled services companies.
buyer: Symphony Technology Group
Symphony Technology Group (STG) is a strategic private equity firm with the mission of investing in and building great software and services companies. STG also provides transformation expertise to enable its companies to deliver maximum value to its clients. "
 target: ImpactRx, Inc.
ImpactRX annually captures three-million treatment decisions, fueling its unique ImpactData™ industry database. ImpactRx leverages this unprecedented intelligence with custom research and analytics to provide insightful solutions to pharmaceutical marketing and sales decision makers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/3/2016 via PR Newswire

IMS Health Incorporated, acquired AlphaImpactRx, Inc

See 82 Comparable Transactions
synopsis: Symphony Technology Group announced the closing of the sale of AlphaImpactRx, a leading provider of primary research and analytics-based insight for biopharmaceutical and consumer health companies to IMS Health, a global information and technology services company serving the healthcare industry.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
 target parent: Symphony Technology Group
target: AlphaImpactRx, Inc
AlphaImpactRx is the leading provider of primary research-based insights, analytics and solutions to pharmaceutical, consumer health and medical device companies. They provide market research to help its global healthcare clients make informed and business decisions to market their products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/18/2011 via PR Newswire

Symphony Technology Group, acquired ImpactRx, Inc.

See 4 Comparable Transactions
synopsis: ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior, announced that Symphony Technology Group (STG), has acquired a majority ownership interest in the Company. STG is a leading private equity firm with a strategic focus on data, analytics and technology-enabled services companies.
buyer: Symphony Technology Group
Symphony Technology Group (STG) is a strategic private equity firm with the mission of investing in and building great software and services companies. STG also provides transformation expertise to enable its companies to deliver maximum value to its clients. "
 target: ImpactRx, Inc.
ImpactRX annually captures three-million treatment decisions, fueling its unique ImpactData™ industry database. ImpactRx leverages this unprecedented intelligence with custom research and analytics to provide insightful solutions to pharmaceutical marketing and sales decision makers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/7/2013 via Wall Street Journal

Wilmington Group plc, acquired NHiS Ltd

See 117 Comparable Transactions
synopsis: Wilmington Group plc, the provider of Information, Compliance, and Education to professional markets announced the acquisition of the entire issued and to be issued share capital of NHiS Limited. NHiS is a leading provider of business intelligence, data analysis, workflow tools and other services to pharmaceutical companies in the UK.
buyer: Wilmington Group plc (LSE:WIL:$162.62)
Wilmington Group plc is a dynamic and expanding company providing information and training to professional business markets. Their businesses enable professionals and their organizations to perform better by providing quality, relevant and reliable information, education and knowledge. "
 target: NHiS Ltd
NHiS is the leading provider of market intelligence and insight to the pharmaceutical sector. NHiS’s products assist organizations in their understanding, engagement and optimization of their markets.
price ($mm)
$8.82
rev ($mm)
$3
EBITDA ($mm)
EV / rev
5.2x
EV / EBITDA
closed 9/13/2011 via PR Newswire

ImpactRx, Inc., acquired TargetRx, Inc.

See 4 Comparable Transactions
synopsis: ImpactRx, a Symphony Technology Group company and the pioneer in measuring the impact of promotion on physician prescribing behavior, announced that it has acquired 100% of TargetRx, Inc., a leading provider of insight into the drivers of physician behavior for pharmaceutical companies.
buyer parent: Symphony Technology Group
buyer: ImpactRx, Inc.
ImpactRx is the leading provider of consultative and analytically-based promotional effectiveness solutions to the healthcare industry. ImpactRx's ImpactData™ is the industry’s sole source of continuous-capture market promotion and physician treatment data. "
 target: TargetRx, Inc.
TargetRx, Inc. is a leading provider of insight into the drivers of physician behavior for pharmaceutical companies. The company offers a suite of solutions from pipeline to patent expiry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/9/2021 via Company Press Release

Telstra Health, will acquire MedicalDirector

See 1003 Comparable Transactions
synopsis: Telstra announced that Telstra Health has entered into a binding agreement to acquire leading GP clinical and practice management software company MedicalDirector. MedicalDirector has been trusted by healthcare practitioners for over 25 years, providing software as a service and innovation to the healthcare industry.
buyer parent: Telstra Corporation Limited
buyer: Telstra Health (ASX:TLS:$20,666.75)
Telstra Health is Australia's largest ehealth company. Telstra Health provides technology solutions that help improve the quality, efficiency and security of health services. They offer products and solutions for electronic medical records, telehealth, back office, medication management and more. "
 target parent: Affinity Equity Partners
target: MedicalDirector
MedicalDirector has been trusted by healthcare practitioners for over 25 years, providing software as a service and innovation to the healthcare industry, including across electronic health records, patient and practice management, billing, scheduling, care coordination, and clinical content.
price ($mm)
$257
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2019 via BusinessWire

Xcenda, acquired Dymaxium, Inc.

See 102 Comparable Transactions
synopsis: Xcenda, a part of AmerisourceBergen, announced the acquisition of Dymaxium, a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
buyer parent: AmerisourceBergen Corporation
buyer: Xcenda
Xcenda, part of AmerisourceBergen, is a strategic consultancy with 20+ years of experience applying real-world expertise in health economics and outcomes research, reimbursement, stakeholder insights, and market access consulting and communications. "
 target: Dymaxium, Inc.
Dymaxium is a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/7/2016 via BNC Analysis

M3, Inc., will acquire Vidal Group

See 55 Comparable Transactions
synopsis: Electra Partners’ portfolio company AXIO Group has received a binding offer from M3 Inc. to purchase Vidal Group, a European provider of reference drug information. Vidal Group provides hospitals, primary care physicians, pharmacists, and patients with on-line access to up-to-date drug databases and related treatment-based information.
buyer: M3, Inc. (TSE:2413:$1,127.03)
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet. "
 target parent: Electra Partners LLP
target: Vidal Group
Vidal Group is a leading European healthcare informatics and information systems company. Vidal Group provides hospitals, primary care physicians, pharmacists, and patients across Europe with on-line access to up-to-date drug databases and related treatment-based information.
price ($mm)
$133
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/18/2016 via BNC Analysis

Affinity Equity Partners, acquired MedicalDirector

See 1067 Comparable Transactions
synopsis: Leading Asian private equity firm Affinity Equity Partners has acquired Sydney-based MedicalDirector (formerly Health Communication Network) from Australia’s Primary Health Care Ltd. MedicalDirector is a leading provider of clinical and enterprise software solutions to general practitioners, medical specialists and allied health professionals.
buyer: Affinity Equity Partners
Affinity Equity Partners is an independently-owned buyout fund manager comprising primarily the former investment professionals of UBS Capital Asia Pacific. They are pioneers in buyout investments in the Asia-Pacific region, with an established and widely recognised franchise. "
 target parent: Primary Health Care Limited
target: MedicalDirector
MedicalDirector has been supporting healthcare professionals and improving health outcomes for more than 20 years. They provide software for practice management, optimizing patient outcomes, and access to Australia's most comprehensive and up-to-date pharmaceutical database.
price ($mm)
$119
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/26/2015 via Company Press Release

Inovalon, Inc., will acquire Avalere Health LLC

See 90 Comparable Transactions
synopsis: Inovalon, a leading technology company providing cloud-based analytics and data-driven intervention platforms to the healthcare industry, has entered into a definitive agreement to acquire Avalere Health, Inc., a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
buyer: Inovalon, Inc. (INOV:$449.36)
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. "
 target: Avalere Health LLC
Avalere Health, Inc. is a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
price ($mm)
$140
rev ($mm)
$47
EBITDA ($mm)
EV / rev
3.0x
EV / EBITDA
closed 6/11/2012 via BNC Analysis

Piramal Healthcare Limited, acquired Decision Resources Group

See 95 Comparable Transactions
synopsis: Piramal Healthcare Limited has completed its previously announced acquisition of Decision Resources Group, a US based company in the healthcare information segment. Decision Resources Group is a cohesive portfolio of companies that offers best in class, high-value information and insights on important sectors of the healthcare industry.
buyer parent: Piramal Group
buyer: Piramal Healthcare Limited
With assets across North America, Europe and Asia, Piramal Healthcare is one of the largest pharmaceutical custom manufacturing companies across the world. It has significant presence in the global critical care space with sales of anesthesia products to over 100 countries. "
 target parent: Providence Equity Partners Inc.
target: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions.
price ($mm)
$635
rev ($mm)
$160
EBITDA ($mm)
EV / rev
4.0x
EV / EBITDA
closed 7/22/2010 via Company Press Release

CT Corsearch, acquired Edital

See 24 Comparable Transactions
synopsis: CT Corsearch, the premier provider of clearance and protection solutions for trademark and brand professionals, announced it’s acquired Edital, the Questel trademark branch. This acquisition will create best-in-class solutions for managing a brand lifecycle globally—from creation to watching to protecting, maintaining and renewing a brand.
buyer parent: Wolters Kluwer NV
buyer: CT Corsearch
CT Corsearch provides high-quality, intuitive tools and expertise that trademark professionals need to effectively manage the trademark screening, search review and watching processes. "
 target parent: Questel
target: Edital
Edital was established in Brussels in 1982 and acquired by Questel, a world leader in Intellectual Property in 2005. Its sole purpose has been to create global solutions for the Intellectual Property professional.
price ($mm)
rev ($mm)
$8
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 9/27/2007 via PR Newswire

Thomson Pharma, acquired Prous Science

See 68 Comparable Transactions
synopsis: The Thomson Corporation, a leading provider of information solutions to business and professional customers worldwide, today announced that it has acquired Prous Science, a global leader in the provision of life sciences information solutions. Prous Science will become part of Thomson Scientific.
buyer parent: The Thomson Corporation
buyer: Thomson Pharma (:$1,614.03)
Thomson Scientific & Healthcare provides integrated information solutions to researchers and librarians, physicians and pharmacists, and other professionals worldwide. "
 target: Prous Science
Prous Science is a trusted source of information on which science depends to discover safer and more effective medicines. The company's products have evolved through the years from print journals to sophisticated electronic products incorporating the latest advances in IT.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2007 via Company Description

MergerMarket, acquired Infinata, Inc.

See 175 Comparable Transactions
synopsis: In September 2007, Mergermarket acquired Infinata, an information solutions and marketing analytics provider to the global financial service, life science, and high technology industries.
buyer parent: Pearson plc
buyer: MergerMarket
MergerMarket, part of Pearson's Financial Times Group, is an unparalleled, independent M&A intelligence tool used by the world's foremost financial institutions to originate deals. It provides proprietary intelligence on potential deal flow, potential mandates and valuations. "
 target: Infinata, Inc.
Infinata is an innovative provider of information solutions and marketing analytics to the global financial service, life science, and high-tech industries. Our information suites include: BioPharm Insight, High Net Worth Insight, and Corporate Tracker.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/28/2020 via Company Press Release

JMDC Inc., will acquire MeCompany

See 64 Comparable Transactions
synopsis: JMDC Inc., a company that provides medical data statistics, life insurance data statistics, health data platform management, and other services, will be acquiring MeCompany, a database company for medical institutions, dispensing pharmacies, and nursing care establishments using the SCUEL database.
buyer: JMDC Inc. (TSE:4483:$162.26)
JMDC Inc. offers information services. The Company provides medical data statistics, life insurance data statistics, health data platform management, and other services. JMDC provides its services throughout Japan. "
 target: MeCompany
Based in Japan, MeCompany is a database company for medical institutions, dispensing pharmacies, and nursing care establishments using the SCUEL database. MeCompany strives to develop a matching service that creates encounters between medical institutions and pharmacies and patients
price ($mm)
$9.76
rev ($mm)
$2
EBITDA ($mm)
EV / rev
4.4x
EV / EBITDA
announced 10/7/2019 via BNC Analysis

Inflexion Private Equity Partners LLP, will acquire Pharmaspectra

See 56 Comparable Transactions
synopsis: Inflexion Private Equity, a UK mid-market private equity firm, will acquire Pharmaspectra, a global provider of medical affairs data to the pharmaceutical and biotech industry. Pharmaspectra offers the world's largest database for medical scientific literature and biomedical literature.
buyer: Inflexion Private Equity Partners LLP
Inflexion is a UK mid-market private equity firm. They invest in high growth, entrepreneurial businesses and work with them to accelerate growth. Inflexion’s flexible approach allows it to back both majority and minority investments, typically investing £10m to £150m of equity in each deal. "
 target: Pharmaspectra
Pharmaspectra is a global provider of medical affairs data to the pharmaceutical and biotech industry. Pharmaspectra offers the world's largest database for medical scientific literature and biomedical literature. Their web-based solutions analyze data across the entire medical continuum.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/6/2017 via PR Newswire

InVitae, acquired AltaVoice

See 60 Comparable Transactions
synopsis: Invitae Corporation has acquired AltaVoice, a privately owned, patient-centered data company with a global platform for collecting, curating, coordinating, and delivering safeguarded data from patients and clinicians.
buyer: InVitae (NVTA:$460.45)
Invitae, a genetic information company, is aggregating the worlds genetic tests into a single service with better quality, faster turnaround time and lower price than most single-gene tests today. Our mission is to bring genetic information into routine medical practice to improve the quality of hea"
 target: AltaVoice
AltaVoice is a patient-centered data company with an innovative story and business model that optimizes the search for better treatments for diseases. They build and host Patient Insights Networks (PINs).
price ($mm)
$5.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/3/2014 via BusinessWire

Fitzroy Health, acquired RJ Health Systems

See 61 Comparable Transactions
synopsis: Fitzroy Health, LLC announced the acquisition of RJ Health Systems International, LLC. RJ Health Systems develops products and services that are designed to offer useable knowledge of pharmaceuticals, including cost, billing, management, and utilization review with the goal of promoting the safe and appropriate use of medication.
buyer: Fitzroy Health
Fitzroy Health is an investment and management firm that helps high potential healthcare companies reach scale by investing capital, managing execution, and developing commercialization and expansion strategies. "
 target: RJ Health Systems
RJ Health Systems develops products and services that are designed to offer useable knowledge of pharmaceuticals, including cost, billing, management, and utilization review with the goal of promoting the safe and appropriate use of medication.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/3/2013 via Company Press Release

JISC Collections, acquired SpringerProtocols

See 95 Comparable Transactions
synopsis: Springer announced that JISC Collections has purchased the archive content of SpringerProtocols; the world’s largest database of life sciences protocols. SpringerProtocols contains more than 31,000 protocols, most of which come from the classic book series “Methods in Molecular Biology”.
buyer: JISC Collections
JISC Collections supports the procurement of digital content for education and research in the UK. They are uniquely placed to provide members with: expertise in negotiating and procurement, within the scholarly communications sector. "
 target parent: EQT
target: SpringerProtocols
SpringerProtocols combines the world’s largest collection of life sciences and bio-medicine protocols with advanced search functionality. Used primarily in the life sciences, the protocols provide sets of instructions that allow scientists to recreate experiments in their own laboratories.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/23/2013 via BNC Analysis

Optum, acquired Humedica

See 983 Comparable Transactions
synopsis: Optum has acquired Humedica. Humedica is the clinical intelligence company that powers health care providers, life sciences and research organizations to make better-informed, more confident decisions by transforming unconnected data from multiple sources into real-world insights.
buyer parent: UnitedHealth Group
buyer: Optum
Optum, through its subsidiaries, provides information and technology-enabled health services. It offers health management solutions that address the physical, mental, and financial needs of individuals and organizations. "
 target: Humedica
Humedica is the clinical intelligence company that powers health care providers and life sciences organizations to make better-informed, more confident decisions by transforming unconnected data from multiple sources into real-world insights.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/9/2012 via BNC Analysis

TechCapital Group, acquired iHealthEcon

See 63 Comparable Transactions
synopsis: TechCapital Group, Life Science Unit has acquired iHealthEcon, a health economics solutions company that helps life sciences organizations plan, develop and advocate health economics to global payers through e-registry-suite.
buyer: TechCapital Group
Established in 1992, TechCapital Group is a private global investment firm that originates, structures and acts as lead equity investor in equity private placements. The R&D management consulting unit provides decision support tools to advanced scientific based engineering groups. "
 target: iHealthEcon
iHealthEcon, through e-registry, offers its clients an innovative suite of decision support tools to advance market access by improving the speed and efficiency of collecting health economics and outcomes research registry data in real time to National Health Systems.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
Pages:  

Like AlphaDetail, Inc.


read more

AlphaDetail, Inc.

Magnolia Innovation, LLC

Kalorama Information

Health Strategies Group

Metanexgen, Inc.

DoctorDirectory.com

Carson Analytics

MD Mindset, LLC

Bell Falla & Associates LLC

Rapidata.net, Inc.

MedePanel

Sermo

Doctors.net.uk

Information Resources, Inc.

Kantar Health

Information Resources, Inc.

The Nielsen Company, Inc.

Synopia RX, LLC

Medical Collective Intelligence Co. Ltd.

PharmARC Analytic Solutions Pvt. Ltd.

Pages:  
read more

AlphaDetail, Inc.

read more

AlphaImpactRx, Inc

Source Healthcare Analytics, LLC

AlphaDetail, Inc.

TargetRx, Inc.

ImpactRx, Inc.

read more

AlphaImpactRx, Inc

ImpactRx, Inc.

NHiS Ltd

TargetRx, Inc.

MedicalDirector

Dymaxium, Inc.

Vidal Group

MedicalDirector

Avalere Health LLC

Decision Resources Group

Edital

Prous Science

Infinata, Inc.

MeCompany

Pharmaspectra

AltaVoice

RJ Health Systems

SpringerProtocols

Humedica

iHealthEcon

Pages:  
Geography
Matching Companies
Ticker: PDII
 
 
 
 
 
 
 
 
PDI, Inc.
PDI, Inc.
PDI is a leading healthcare commercialization company providing go-to-market strategy and execution to established and emerging pharmaceutical, biotechnology, diagnostics and healthcare companies in the United States.
year
2015
rev ($mm)
$140.12
EBITDA ($mm)
($14.89)
EBIT ($mm)
($19.53)
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3, Inc.
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet.
year
2019
rev ($mm)
$1,127.03
EBITDA ($mm)
$319.84
EBIT ($mm)
$286.78
Net Income ($mm)
$193.56
Employees
6024
  • drill down
  • watch
Ticker: TSE:4483
 
 
 
 
 
 
 
 
JMDC Inc.
JMDC Inc.
JMDC Inc. offers information services. The Company provides medical data statistics, life insurance data statistics, health data platform management, and other services. JMDC provides its services throughout Japan.
year
2022
rev ($mm)
$162.26
EBITDA ($mm)
$48.62
EBIT ($mm)
$36.21
Net Income ($mm)
$24.23
Employees
966
  • drill down
  • watch